Literature DB >> 33588989

A paucigranulocytic asthma host environment promotes the emergence of virulent influenza viral variants.

Katina D Hulme1, Anjana C Karawita1, Cassandra Pegg1, Myrna Jm Bunte1, Helle Bielefeldt-Ohmann1,2,3, Conor J Bloxham4, Silvie Van den Hoecke5,6, Yin Xiang Setoh1,2,7, Bram Vrancken8, Monique Spronken9, Lauren E Steele1, Nathalie Aj Verzele1, Kyle R Upton1, Alexander A Khromykh1,2, Keng Yih Chew1, Maria Sukkar10, Simon Phipps2,11, Kirsty R Short1,2.   

Abstract

Influenza virus has a high mutation rate, such that within one host different viral variants can emerge. Evidence suggests that influenza virus variants are more prevalent in pregnant and/or obese individuals due to their impaired interferon response. We have recently shown that the non-allergic, paucigranulocytic subtype of asthma is associated with impaired type I interferon production. Here, we seek to address if this is associated with an increased emergence of influenza virus variants. Compared to controls, mice with paucigranulocytic asthma had increased disease severity and an increased emergence of influenza virus variants. Specifically, PB1 mutations exclusively detected in asthmatic mice were associated with increased polymerase activity. Furthermore, asthmatic host-derived virus led to increased disease severity in wild-type mice. Taken together, these data suggest that at least a subset of patients with asthma may be more susceptible to severe influenza and may be a possible source of new influenza virus variants.
© 2021, Hulme et al.

Entities:  

Keywords:  asthma; host-pathogen evolution; human; immunology; infectious disease; inflammation; influenza virus; interferons; microbiology; mouse; mutation

Mesh:

Substances:

Year:  2021        PMID: 33588989      PMCID: PMC7886327          DOI: 10.7554/eLife.61803

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  51 in total

1.  Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial.

Authors:  Herman J Bueving; Roos M D Bernsen; Johan C de Jongste; Lisette W A van Suijlekom-Smit; Guus F Rimmelzwaan; Albert D M E Osterhaus; Maureen P M H Rutten-van Mölken; Siep Thomas; Johannes C van der Wouden
Journal:  Am J Respir Crit Care Med       Date:  2003-12-04       Impact factor: 21.405

2.  The burden of influenza illness in children with asthma and other chronic medical conditions.

Authors:  K M Neuzil; P F Wright; E F Mitchel; M R Griffin
Journal:  J Pediatr       Date:  2000-12       Impact factor: 4.406

3.  Influenza-induced inflammation drives pneumococcal otitis media.

Authors:  Kirsty R Short; Patrick C Reading; Lorena E Brown; John Pedersen; Brad Gilbertson; Emma R Job; Kathryn M Edenborough; Marrit N Habets; Aldert Zomer; Peter W M Hermans; Dimitri A Diavatopoulos; Odilia L Wijburg
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

4.  A reassortant H9N2 influenza virus containing 2009 pandemic H1N1 internal-protein genes acquired enhanced pig-to-pig transmission after serial passages in swine.

Authors:  José Carlos Mancera Gracia; Silvie Van den Hoecke; Juergen A Richt; Wenjun Ma; Xavier Saelens; Kristien Van Reeth
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

5.  Naturally occurring mutations in PB1 affect influenza A virus replication fidelity, virulence, and adaptability.

Authors:  Ruey-Wen Lin; Guang-Wu Chen; Hsiang-Hsuan Sung; Ren-Jye Lin; Li-Chen Yen; Yu-Ling Tseng; Yung-Kun Chang; Shu-Pei Lien; Shin-Ru Shih; Ching-Len Liao
Journal:  J Biomed Sci       Date:  2019-07-31       Impact factor: 8.410

6.  A paucigranulocytic asthma host environment promotes the emergence of virulent influenza viral variants.

Authors:  Katina D Hulme; Anjana C Karawita; Cassandra Pegg; Myrna Jm Bunte; Helle Bielefeldt-Ohmann; Conor J Bloxham; Silvie Van den Hoecke; Yin Xiang Setoh; Bram Vrancken; Monique Spronken; Lauren E Steele; Nathalie Aj Verzele; Kyle R Upton; Alexander A Khromykh; Keng Yih Chew; Maria Sukkar; Simon Phipps; Kirsty R Short
Journal:  Elife       Date:  2021-02-16       Impact factor: 8.140

7.  Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation.

Authors:  Florence N Schleich; Maité Manise; Jocelyne Sele; Monique Henket; Laurence Seidel; Renaud Louis
Journal:  BMC Pulm Med       Date:  2013-02-26       Impact factor: 3.317

Review 8.  Influenza A(H1N1)pdm09 virus and asthma.

Authors:  Masatsugu Obuchi; Yuichi Adachi; Takenori Takizawa; Tetsutaro Sata
Journal:  Front Microbiol       Date:  2013-10-14       Impact factor: 5.640

9.  High glucose levels increase influenza-associated damage to the pulmonary epithelial-endothelial barrier.

Authors:  Katina D Hulme; Limin Yan; Rebecca J Marshall; Conor J Bloxham; Kyle R Upton; Sumaira Z Hasnain; Helle Bielefeldt-Ohmann; Zhixuan Loh; Katharina Ronacher; Keng Yih Chew; Linda A Gallo; Kirsty R Short
Journal:  Elife       Date:  2020-07-22       Impact factor: 8.140

View more
  3 in total

1.  A paucigranulocytic asthma host environment promotes the emergence of virulent influenza viral variants.

Authors:  Katina D Hulme; Anjana C Karawita; Cassandra Pegg; Myrna Jm Bunte; Helle Bielefeldt-Ohmann; Conor J Bloxham; Silvie Van den Hoecke; Yin Xiang Setoh; Bram Vrancken; Monique Spronken; Lauren E Steele; Nathalie Aj Verzele; Kyle R Upton; Alexander A Khromykh; Keng Yih Chew; Maria Sukkar; Simon Phipps; Kirsty R Short
Journal:  Elife       Date:  2021-02-16       Impact factor: 8.140

Review 2.  The influenza virus RNA polymerase as an innate immune agonist and antagonist.

Authors:  Elizaveta Elshina; Aartjan J W Te Velthuis
Journal:  Cell Mol Life Sci       Date:  2021-10-22       Impact factor: 9.261

3.  Next-generation T cell-activating vaccination increases influenza virus mutation prevalence.

Authors:  Maireid B Bull; Haogao Gu; Fionn N L Ma; Liyanage P Perera; Leo L M Poon; Sophie A Valkenburg
Journal:  Sci Adv       Date:  2022-04-06       Impact factor: 14.957

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.